San Raffaele University of Rome at PEGS Europe 2026

Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website

San Raffaele University of Rome brings 2 presentations to PEGS Europe 2026 in Lisbon. Its program covers insulin neoepitopes created by post-translational modification as possible targets for diagnosing and treating type 1 diabetes, shared with Queen Mary University of London. It also appears in the antibody-based therapies track.

OrganizationPEGS Europe 2026 Attendance
Chair
Tue Nov 17
8:25am–8:30am
Chairperson's Remarks
Antibody-Based Therapies
Talk
Wed Nov 18
3:05pm–3:35pm
Special Presentation: Post-Translational Modified Insulin Neoepitopes—Potential Targets in Type 1 Diabetes Diagnosis and Treatment
Biologics for Autoimmune Diseases · with Queen Mary University of London

Explore the full PEGS Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Lisbon. Leave your work email and we’ll be in touch.

Privacy

Download the full PEGS Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at San Raffaele University of Rome

Tell us what you sell and we’ll find the people at San Raffaele University of Rome most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by PEGS Europe or its organizers. Submit a correction